CBLL - CeriBell, Inc. Stock Analysis | Stock Taper
Logo

About CeriBell, Inc.

https://ceribell.com

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders.

Xingjuan Chao

CEO

Xingjuan Chao

Compensation Summary
(Year 2024)

Salary $494,500
Option Awards $1,013,233
Incentive Plan Pay $278,055
All Other Compensation $32,741
Total Compensation $1,818,529
Industry Medical - Devices
Sector Healthcare
Went public October 11, 2024
Full time employees 281

ETFs Holding This Stock

Ratings Snapshot

Rating : C

Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 3
Price To Earnings 1
Price To Book 3
Overall Score 2

Most Recent Analyst Grades

Grade Summary

Buy 3
Overweight 1

Showing Top 4 of 4

Price Target

Target High $30
Target Low $30
Target Median $30
Target Consensus $30

Institutional Ownership

Summary

% Of Shares Owned 62.04%
Total Number Of Holders 102

Showing Top 3 of 102